Sign up for the newsletter
Biotech's promises for the future: turning challenges into opportunities
ORGANIZED BY: The Organizer of each Conference Session is mentioned within the following programme.
LOCATION: FieraMilano - Rho - The Hall and the Room of each Conferences Sessions are mentioned within the following programme.
ENTRANCE: The access to the Conference is free, upon payment of the Fair ticket.
REGISTRATION: Participants are adviced to report to the Conference Reception well in advance; at least, 20 minutes before the start of the session.
LANGUAGE: Unless otherwise specified, Conference Presentations will be in English; simultaneous translation will not be provided.
* provisional title
** invited chair/speaker
Wednesday, November 25th 2009
Argento Conference Room, pav. 18 - The session will be held in Italian | |
Chair: Leonardo Santi (National Committee for Biosafety and Biotechnology) | |
2.00pm-2.10pm | Chairman's address |
2.10pm-2.20pm | Malattie rare e farmaci orfani: a che punto siamo a livello europeo e nazionale? |
2.20pm-2.30pm | L'impegno di Farmindustria nelle malattie rare |
2.30pm- 2.40pm | Dalla ricerca e sviluppo all'accesso: il ruolo dell'Industria |
2.40pm-2.50pm | Empowerment sociale e sostenibilità |
2.50pm-3.00pm | Le malattie rare nel progetto 2015 nuove tecnologie per la vita |
3.00pn-3.10pm | Discussion |
Argento Conference Room - pav. 18 - The session is sponsored by Assogenerici - The session will be held in Italian | |
Chair: prof. Leonardo Santi (National Committee for Biosafety and Biotechnology) | |
3.30pm - 3.40pm | Chairman's address |
3.40pm - 3.50pm | Biosimilars: from European Guidelines to management |
3.50pm - 4.00pm | Biosimilars: Quality and sustainability |
4.00pm - 4.10pm | Perspectives for biological drugs |
4.10pm - 4.20pm | Biosimilars: challenges and opportunities |
4.20pm - 4.30pm | The evaluation and the choice of a biosimilar drug in a public hospital based on safety, efficacy, effectiveness and cost-effectiveness by a combined analisys |
4.30pm - 4.45pm | Biosimilars, the industry's position |
4.45pm - 5.00pm | Discussion |
Platino Conference Room , pav. 18 | |
Chair: Paolo Barbanti (Pharma & Biotech Advisors) | |
3.00pm-3.15pm | NiKem Research: a CRO focused on emerging technologies and quality in ADMET & PK |
3.15pm -3.30pm | High-potency API manufacturing by Sochinaz |
3.30pm-3.45pm | Trifunctional antibodies - exposing cancer to the power of immune response |
3.45pm-4.00pm | Vitrology, a GMP BioSafety Quality Control sub-contractors for biotech drugs - Company history, overview & key factors of success |
4.00pm-4.15pm | Assign Group - your experienced CRO partner in biotech clinical research |
4.15pm-4.30pm | Discussion |
Thursday, Novembre 26th 2009
Argento Conference Room, pav. 18 | |
Chair: Marco Pierotti (Foundation IRCCS - Istituto Nazionale Tumori) | |
10.00am-10.15am | Chairman's address |
10.15am-10.25am | Targeted Immunity for the treatment of cancer |
10.25am-10.35am | Development of Personalized Treatments for Cancer at AstraZeneca |
10.35am-10.45am | Regulation of self-renewal in Cancer Stem Cells |
10.45am-11.00am | A translational medicine approach for the development of novel VEGF/FGF inhibitor E-3810 |
11.00pm-11.20pm | Discussion |
Organized in co-operation with NFI - Nutrition Foundation of Italy, Platino Conference Room, pav. 18 | |
Chair: Rodolfo Paoletti (President NFI) | |
10.00am-10.10am | Chairman's address |
10.10am-10.25am | OMEGA 3 bioavailability: role of matrix, gender and metabolism |
10.25am-10.40am | Coffee. A multi-functional ingredient food |
10.40am-10.55am | Green tea as functional food: focus on weight control |
10.55am-11.10am | Discussion |
Argento Conference Room, pav. 18 | |
Chairs: Marco Klinger (University of Milan, Department of Plastic Surgery - IRCCS Istituto Clinico Humanitas) | |
11.30am-11.35am | Chairmen's address |
11.35am-11.45am | Regenerative properties of autologous fat graft: from aesthetic to reconstructive surgery |
11.45am-11.55am | Corneal epithelium: 10 years of translational medicine |
11.55am-12.05am | The use of neural stem cells for regenerating the nervous system |
12.05am-12.15am | Cell therapy for muscular dystrophy |
12.15am-12.25am | Stem cells and skin repair |
12.25am-12.40am | Quality requirements in stem cells production |
12.40am-1.00pm | Discussion |
Platino Conference Room, pav. 18 - Organized in co-operation with PROMOS and Regione Lombardia | |
Chair: Anna Gervasoni (Executive Director AIFI) | |
11.10am-11.20am | Chairman's address |
11.20am-11.30am | Ernst & Young's Global Biotechnology Report 2009 |
11.30am-11.40am | The role of the European Patent Office in supporting innovation |
11.40am-11.50am | Financing innovation: the Lombardy Region approach |
11.50am-12.40am | The role of venture capital |
12.40am-12.50am | Discussion |
Argento Conference Room, pav. 18 | |
Chair: Guido Grandi (Novartis) | |
2.00pm - 2.10pm | Chairman's address |
2.10pm - 2.20pm | Marco Ercolani (Direttore Medico Prevenzione - GlaxoSmithKline) |
2.20pm-2.30pm | Vaccines for adults and the elderly |
2.30pm-2.40pm | The development of a vaccine against the novel influenza A H1N1 pandemic virus |
2.40pm-2.50pm | Antibody vaccine development and manufacturing |
2.50pm-3.00pm | Sensitive drug and primary container interactions |
3.00pm-3.15 pm | Discussion |
Platino Conference Room, pav. 18 | |
Chair: Emil Abirascid (Chief Editor of Inn'ovazione ) | |
2.00pm-2.10pm | Welcome introduction |
2.10pm-2.25pm | AREA Science Park Trieste |
2.25pm-2.40pm | Bioindustry Park del Canavese |
2.40pm-2.55pm | Insubrias Biopark |
2.55pm-3.10pm | Parco Tecnologico Padano |
3.10pm-3.25pm | Parco Scientifico e Tecnologico della Sicilia |
3.25pm-3.40pm | Sardegna Ricerche |
3.40pm-3.55pm | Technapoli |
3.55pm-4.10pm | Toscana Life Sciences Foundation |
Argento Conference Room, pav. 18 | |
Chair: Maurizio Ferrari (Director of Clinical Molecular Biology Lab, San Raffaele Hospital) | |
3.30pm - 3.40pm | |
3.40pm - 3.50pm | Pharmacogenomics: genetic variants and personalized therapies |
3.50pm - 4.00pm | Loxin Test: an aid for the assesment of cardiovascular risk |
4.00pm - 4.10pm | The "GOLDChip" microarray in prenatal diagnosis |
4.10pm-4.20pm | Rapidity and highthroughput in the prenatal diagnosis of the most common chromosomal aneuploidies |
4.20pm- 4.45pm | Discussion |
Friday, November 27th November 2009
Argento Conference Room, pav. 18 - Session sponsored by EON Medica, IGEA, AT Grade and MIDA Tecnologia Medica | |
Chairs: Dario Capitani (A.O. Ospedale Niguarda Ca' Granda) | |
10.00am-10.15am | Cartilage Regeneration: state of the art |
10.15am-10.25am | Basic science in "one step" and "two steps" cartilage regeneration techniques |
10.25am-10.40am | Autologous Chondrocyte Transplantation 10 years later: where are we? |
10.35am-10.55am | Autologus condricytes implantation on scaffolds: concepts and clinical results |
10.55am-11.10am | Smart biomimetic scaffolds in the osteochondral tissue regeneration |
11.00am-11.25am | Treatment of condral defects with collagen membrane and mesenchymal stem cells |
11.25am-11.40am | Cartilage regeneration and electrical stimulation |
11.40am-11.55am | A new technology in cartilage tissue regeneration |
11.55am-12.10am | Discussion |
Platino Conference Room, pav. 18 | |
Chair: Fabrizio Conicella (Bioindustry Park del Canavese) | |
10.00am-10.10am | Chairman's address |
10.10am-10.50am | The value of transnational research for the young biotech companies |
| EUROTRANS-BIO experience in promoting transnational R&D projects: results and perspectives |
| The European Innovative Medicines Initiative (IMI): challenges and opportunities |
10.50am-11.10am | A first case of a company involved into a transnational R&D project |
| A second case of a company involved into a transnational R&D project |
11.10am-11.30am | Discussion |
11.30am-12.50am | Workshop |
| Mordechay Sheves (Vice President for Technology Transfer Weizmann Institute of Science) |
| Giampiero de Luca (Vice President Intellectual Property and Licensing-Merck Serono - Geneva - Switzerland) |
| Giuseppe Martini (Director Department of Life Science - CNR - Italy) |
| Riccardo Pietrabissa (President Netval and Pro Rettore Vicario (Lecco) Politecnico di Milano - Italy) |
| Dario Neri (ETH Professor and Co-Founder, Scientific Director Philogen SpA - Italy) |
